{"transactions":[{"id":947106,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CDO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T20:00:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":2.18,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001493152-26-000696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000149315226000696/ownership.xml","form_type":"4"}},{"id":1303632,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CDO"}}],"security":"Stock Option (right  to buy)","published_at":"2025-01-14T18:57:09.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":20000,"derivative":{"exercise_price":1.38,"exercise_date":"2025-01-14","expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-25-000413","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000165495425000413/section16.xml","form_type":"4"}},{"id":1685769,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CDO"}}],"security":"Stock Option (right to buy","published_at":"2024-01-05T21:01:23.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the\n12 month anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":0.6099,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-24-000295","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000165495424000295/section16.xml","form_type":"4"}},{"id":2063120,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CDO"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T16:06:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":0.31,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001654954-23-000146","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000165495423000146/section16.xml","form_type":"4"}},{"id":2210856,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CDO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-07T20:04:08.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":30000,"derivative":{"exercise_price":0.513,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001654954-22-009392","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000165495422009392/section16.xml","form_type":"4"}},{"id":2444526,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Development"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T19:22:39.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":30000,"derivative":{"exercise_price":1.88,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905718-22-000052","document":"dermata_fm4jan32022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000090571822000052/dermata_fm4jan32022.xml","form_type":"4"}},{"id":2600632,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Development"}}],"security":"Series 1 Preferred Stock","published_at":"2021-08-17T12:39:47.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Nardo Family Trust Dated October 3, 2001"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2439},"source":{"system":"sec-edgar","filing":"0000905718-21-001096","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000090571821001096/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600631,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70039,"kind":"person","name":"Nardo Christopher J.","position":1,"cik":"0001870247","reported_name":"Nardo Christopher J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Development"}}],"security":"Common Stock","published_at":"2021-08-17T12:39:47.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":2439,"ownership":{"direct":false,"nature":"By Nardo Family Trust Dated October 3, 2001"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2439,"source":{"system":"sec-edgar","filing":"0000905718-21-001096","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1870247/000090571821001096/dermata_fm4aug172021.xml","form_type":"4"}}]}